Uli Fruth
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Leprosy Research and Treatment
- Immunology top 10%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune responses and vaccinations
Papers in
-
- Tuberculosis Research and Epidemiology 10
- Leprosy Research and Treatment 2
-
- Protease and Inhibitor Mechanisms 7
- Co-authors
- Markus M. Simon (11 shared papers)Michael D. Kramer (9 shared papers)Hans‐Georg Simon (7 shared papers)Michael J. Brennan (6 shared papers)Kenneth Barry Walker (3 shared papers)Heinz Hoschützky (1 shared paper)Mei Mei Ho (2 shared papers)Roland Dobbelaer (2 shared papers)
- Journals
- Vaccine (5 papers)European Journal of Immunology (4 papers)Tuberculosis (2 papers)PLoS Medicine (2 papers)Advances in experimental medicine and biology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Uli Fruth
27 papers receiving 868 citations
Peers
Comparison fields: 5 of 37
- Infectious Diseases 420
- Immunology 103
- Cancer Research 64
- Microbiology 20
- Virology 4
Countries citing papers authored by Uli Fruth
This map shows the geographic impact of Uli Fruth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uli Fruth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uli Fruth more than expected).
Fields of papers citing papers by Uli Fruth
This network shows the impact of papers produced by Uli Fruth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uli Fruth. The network helps show where Uli Fruth may publish in the future.
Co-authors
The 25 scholars most cited alongside Uli Fruth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 106 | |
| 2 | 1986 | 101 | |
| 3 | 2010 | 91 | |
| 4 | 2008 | 75 | |
| 5 | 2013 | 73 | |
| 6 | Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-like serine proteinase. | 1987 | 62 |
| 7 | 1987 | 49 | |
| 8 | 2000 | 42 | |
| 9 | 1989 | 38 | |
| 10 | 2007 | 38 | |
| 11 | 2014 | 38 | |
| 12 | 2004 | 37 | |
| 13 | 1987 | 35 | |
| 14 | Release of biologically active fragments from human plasma-fibronectin by murine T cell-specific proteinase 1 (TSP-1). | 1988 | 29 |
| 15 | 1989 | 25 | |
| 16 | Prospects for new TB vaccines: Stop TB Working Group on TB Vaccine Development. | 2004 | 20 |
| 17 | 1988 | 14 | |
| 18 | 2001 | 14 | |
| 19 | 1988 | 9 | |
| 20 | 2000 | 8 |
About Uli Fruth
Uli Fruth is a scholar working on Infectious Diseases, Cancer Research, Immunology, Virology and Molecular Biology, having authored 27 papers that have together received 933 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Protease and Inhibitor Mechanisms (7 papers), T-cell and B-cell Immunology (3 papers), Leprosy Research and Treatment (2 papers), HIV Research and Treatment (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Infectious Diseases (420 citations), Immunology (103 citations), Cancer Research (64 citations), Microbiology (20 citations) and Virology (4 citations). Uli Fruth has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Markus M. Simon, Michael D. Kramer, Hans‐Georg Simon, Michael J. Brennan, Kenneth Barry Walker, Heinz Hoschützky, Mei Mei Ho, Roland Dobbelaer, Hazel M. Dockrell and Marlot Prester. Their work appears in journals such as Vaccine, European Journal of Immunology, Tuberculosis, PLoS Medicine and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.